Delivery Order SPE2DB22D3301-SPE2DB24FY8KF
Award Date 6/12/24
Potential Completion Date 7/5/24
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $11,435.46 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YERVOY 50 MG/10 ML VIAL 10ML pharmaceutical products, with a period of performance through July 3, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563875830 YERVOY 50 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The delivery order has a potential value of $18,459.12 and a completion date of March 27, 2024. This order is placed under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and...
- The U.S. Defense Logistics Agency (DLA) awarded a $10,811.72 firm fixed price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division to supply 4564881403 ! YERVOY 50 MG/10 ML VIAL 10ML. This order is part of a larger single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between DLA Troop Support Medical and Amerisourcebergen, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $10,811.72 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563513327 - YERVOY 50 MG/10 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,142,126 units of the medication YERVOY 50 MG/10 ML VIAL 10ML. The contract has a ceiling value of $22,870.92 and a period of performance through May 27, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,435.46, is for the supply of YERVOY 50 MG/10 ML VIAL 10ML, a medication used in the treatment of certain types of cancer. The contract has an ultimate completion date of May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide YERVOY 50 MG/10 ML VIAL 10ML. The $11,435.46 Firm Fixed Price Delivery Order contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $21,623.40, is for the supply of the pharmaceutical product YERVOY 50 MG/10 ML VIAL 10ML. The delivery order falls under a larger $999,999,999.00 indefinite delivery contract held by Amerisourcebergen Drug Corp to provide a comprehensive range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor. The contract is for the pharmaceutical product YERVOY 50 MG/10 ML VIAL 10ML, with a completion date of February 27, 2024 and a potential value of $21,623.40. Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, has an indefinite delivery contract (IDC) with DLA with a potential...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,870.92, is for the delivery of YERVOY 50 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The contract has a completion date of April 8, 2025 and is a firm fixed-price delivery order. There is no set-aside designation on this contract. Amerisourcebergen...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY8KFDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $21,614.14, for the supply of the pharmaceutical product YERVOY 200 MG/40 ML VIAL 40ML. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for military treatment programs and facilities globally. This specific order does not have a set-aside designation.
Generated 9/11/24, 11:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.6k | 6/12/24 |